title: Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer.
authors.affiliation: Medical Oncology Department, Istituto Oncologico Veneto/IRCCS, Via Gattamelata 64, 35128 Padova, Italy. grazia.artioli@yahoo.it
authors.forename: Grazia
authors.initials: G
authors.lastname: Artioli
authors.forename: Artioli
authors.initials: A
authors.lastname: Grazia
authors.forename: Simone
authors.initials: S
authors.lastname: Mocellin
authors.forename: Mocellin
authors.initials: M
authors.lastname: Simone
authors.forename: Lucia
authors.initials: L
authors.lastname: Borgato
authors.forename: Borgato
authors.initials: B
authors.lastname: Lucia
authors.forename: Alessandro
authors.initials: A
authors.lastname: Cappetta
authors.forename: Cappetta
authors.initials: C
authors.lastname: Alessandro
authors.forename: Fernando
authors.initials: F
authors.lastname: Bozza
authors.forename: Bozza
authors.initials: B
authors.lastname: Fernando
authors.forename: Giorgio
authors.initials: G
authors.lastname: Zavagno
authors.forename: Zavagno
authors.initials: Z
authors.lastname: Giorgio
authors.forename: Stefania
authors.initials: S
authors.lastname: Zovato
authors.forename: Zovato
authors.initials: Z
authors.lastname: Stefania
authors.forename: Alberto
authors.initials: A
authors.lastname: Marchet
authors.forename: Marchet
authors.initials: M
authors.lastname: Alberto
authors.forename: Davide
authors.initials: D
authors.lastname: Pastorelli
authors.forename: Pastorelli
authors.initials: P
authors.lastname: Davide